Maryvonne Hiance
About
Maryvonne Hiance is from Greater Nantes Metropolitan Area. Maryvonne works in the following industries: "Biotechnology Research". Maryvonne is currently Chairman at HealthTech For Care. Maryvonne also works as Vice-présidente at OSE Immunotherapeutics, a job Maryvonne has held since Jun 2016. In Maryvonne's previous role as a Vice Chairman at France Biotech, Maryvonne worked in until Dec 2021. Prior to joining France Biotech, Maryvonne was a Chairman at France Biotech and held the position of Chairman at PARIS. Prior to that, Maryvonne was a Chairman at Effimune, based in www from Jul 2008 to May 2016. Maryvonne started working as Managing Director at DRUGABUSE SCIENCES SAS in Paris, France in Jan 1999. From Jan 1990 to Jan 1994, Maryvonne was Managing Director at SANGSTAT ATLANTIQUE.
Go to finalscout.com and type Maryvonne Hiance's name into the search box for a free email address. FinalScout is a professional database with more than 500 million business professionals and 200 million company executives.
Maryvonne Hiance's current jobs
The HealthTech For Care endowment fund, launched by France Biotech, is designed to support and promote access to care for all and, more specifically, to new medical technologies and drugs. The missions of the endowment fund are structured around three main areas: Supporting the development of the entire health ecosystem, accelerating the development of innovative therapies and treatments, and promoting better access to healthcare for patients in the French healthcare system and more widely throughout Europe.
OSE Immunotherapeutics is a biotechnology company focused on the development of innovative immunotherapies for immune activation and regulation in the fields of immuno-oncology, auto-immune diseases and transplantation.
Maryvonne Hiance's past jobs
France Biotech is the association of French companies in the Life Sciences sector and their partners. Its mission is to contribute to domestic growth in this innovative industry and to support France’s leadership role within the European Life Sciences community.
Effimune is a biotechnology company specializing in the research and development of therapeutics molecules that regulate the immune system in the areas of transplantation, autoimmunity and cancer.